About this trial
This intensive longitudinal study investigates the day-to-day stability and natural fluctuations of the gut microbiome in healthy adults over a 15-day period. While the human gut microbiome is a complex ecosystem, its baseline stability in the absence of disease or medical intervention remains insufficiently characterized due to low sampling frequency in prior research. By recruiting healthy volunteers for continuous daily sampling, this study aims to map temporal community structures and evaluate the stability of core microbiota. Additionally, the research utilizes Continuous Glucose Monitoring (CGM) to explore the potential relationships between microbiome dynamics, daily dietary intake, and host glycemic stability.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Participants reside in Hangzhou
Disqualifiers
Refusing or unable to give informed consent
Participants with chronic gastrointestinal diseases and take daily relevant medications
Participants with metabolic diseases including diabetes, hypertension and cardiovascular diseases (CVD)
Participants with craniocerebral trauma, cancer, liver disease, kidney disease, or other critical illness, or history of operation or medication
Trial population
Healthy young adults residing in Hangzhou
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Gut microbiome
Using qPCR, metagenomics, metabolomics, proteomics, and culturomics, we quantified the composition and absolute abundance of the gut microbiota and characterized its short-term and long-term dynamics.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.